Zobrazeno 1 - 10
of 96
pro vyhledávání: '"G. Koleva"'
Publikováno v:
Urology Case Reports, Vol 43, Iss , Pp 102067- (2022)
Hemangiomas are benign vascular lesion, most commonly seen in liver and skin. Urethral hemangiomas are very rare benign vascular tumors with varying size and usually present as urethral bleeding or hematuria. We are presenting a 64 years old male, wh
Externí odkaz:
https://doaj.org/article/e4d8512c339843b0927cf212a9028710
Publikováno v:
Urology Case Reports, Vol 35, Iss , Pp 101554- (2021)
Retroperitoneal primitive neuroectodermal tumors (PNET) is a rare neoplastic disease of high malignancy with a tendency towards early metastasis, affect young adults irrespective of the gender. We present 81 year old woman, who was admitted in the Ur
Externí odkaz:
https://doaj.org/article/7ff2bcba6b1342b3bbcb33c94bb3439c
Autor:
Philip Chowienczyk, Julia Fox-Rushby, Ka Keat Lim, Charles D.A. Wolfe, Rositsa G Koleva-Kolarova
Publikováno v:
The Pharmacogenomics Journal
Despite the known contributions of genes, genetic-guided pharmacotherapy has not been routinely implemented for venous thromboembolism (VTE). To examine evidence on cost-effectiveness of genetic-guided pharmacotherapy for VTE, we searched six databas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bea8e5012cf0ed43cc46bb95e4357648
https://doi.org/10.1038/s41397-021-00243-7
https://doi.org/10.1038/s41397-021-00243-7
Publikováno v:
AIP Advances, Vol 4, Iss 4, Pp 047105-047105-10 (2014)
Many papers have sought correlations between the parameters of secondary particles generated above the beam/work piece interaction zone, dynamics of processes in the keyhole, and technological processes. Low- and high-frequency oscillations of the cu
Externí odkaz:
https://doaj.org/article/6e9039f2fc32433b961d5dfa742b59bc
Autor:
Vasa Curcin, Ewan Ferlie, Charles D.A. Wolfe, Sylvia Edwards, Maria Kordowicz, Julia Fox-Rushby, Tessa Crilly, Mark Ashworth, Archana Tapuria, Rositsa G Koleva-Kolarova
Publikováno v:
MIE
The aim of the Foundation Healthcare Group (FHG) Vanguard model was to develop a sustainable local hospital model between two National Health Service (NHS) Trusts (a London Teaching Hospital Trust and a District General Hospital Trust) that makes bes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::734dcfcb70b8f4a1f99578837562b6a5
https://doi.org/10.3233/shti210246
https://doi.org/10.3233/shti210246
Autor:
Julia Fox-Rushby, Ewan Ferlie, Sylvia Edwards, Charles D.A. Wolfe, Maria Kordowicz, Tessa Crilly, Rositsa G Koleva-Kolarova, Vasa Curcin, Archana Tapuria, Mark Ashworth
The goal of the Foundation Healthcare Group (FHG) Vanguard model was to develop a sustainable local hospital model between two National Health Service (NHS) Trusts (a London Teaching Hospital Trust and a District General Hospital Trust) that makes be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d2c1538656f13d6b659130a8f705707
Autor:
Erik F. J. de Vries, David Parkin, Marcel J. W. Greuter, Rositsa G Koleva-Kolarova, Talitha L Feenstra, Erik Buskens, Geertruida H. de Bock, Karin M. Vermeulen
Publikováno v:
Oncotarget
Oncotarget, 9(28), 19836-19846. Impact Journals LLC
Koleva-Kolarova, R G, Greuter, M J W, Feenstra, T L, Vermeulen, K M, de Vries, E F J, Parkin, D, Buskens, E & de Bock, G H 2018, ' Molecular imaging with positron emission tomography and computed tomography (PET/CT) for selecting first-line targeted treatment in metastatic breast cancer: a cost-effectiveness study ', Oncotarget, vol. 9, no. 28, pp. 19836-19846 . https://doi.org/10.18632/oncotarget.24869
Oncotarget, 9(28), 19836-19846. Impact Journals LLC
Koleva-Kolarova, R G, Greuter, M J W, Feenstra, T L, Vermeulen, K M, de Vries, E F J, Parkin, D, Buskens, E & de Bock, G H 2018, ' Molecular imaging with positron emission tomography and computed tomography (PET/CT) for selecting first-line targeted treatment in metastatic breast cancer: a cost-effectiveness study ', Oncotarget, vol. 9, no. 28, pp. 19836-19846 . https://doi.org/10.18632/oncotarget.24869
Our aim was to evaluate the potential cost-effectiveness of PET/CT with FES and 89Zr-trastuzumab compared to pathology to select first-line targeted treatment in metastatic breast cancer (MBC) patients with non-rapidly progressive disease. A previous
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a8d201dcc7ff72b4683bb9cf3486c409
http://europepmc.org/articles/PMC5929430
http://europepmc.org/articles/PMC5929430
Publikováno v:
Value in Health. 24:S195
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::434e5f4f76f789b60aff7665fdaa05b1
https://doi.org/10.1016/j.jval.2021.04.975
https://doi.org/10.1016/j.jval.2021.04.975
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Marcel J. W. Greuter, Zhuozhao Zhan, Ruud M. Pijnappel, Talitha L Feenstra, C. De Jonge, M.K. Abu Hantash, G. H. de Bock, Erik Jan Postema, Rositsa G Koleva-Kolarova
Publikováno v:
European Journal of Cancer, 92(Supp. 3), S11-S12. ELSEVIER SCI LTD
European Journal of Cancer, 92, S11-S12. ELSEVIER SCI LTD
European Journal of Cancer, 92, S11-S12. ELSEVIER SCI LTD
Background: Increased breast cancer incidence between 45 and 50 years of age requires reconsideration of the current starting age of routine mammography. Our aim was to evaluate the quantitative benefits, harms, and cost-effectiveness of lowering the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::95f9ee585e3e6b78f45cb0b8aa126a0b
https://research.rug.nl/en/publications/2df775b8-af49-484a-b2a9-8ace5cfa950c
https://research.rug.nl/en/publications/2df775b8-af49-484a-b2a9-8ace5cfa950c